Endometrial ablation with the NovaSure system in Iran

被引：22

作者：

Asgari, Zahra ^{[1
]}

Moini, Ashraf ^{[1
]}

Samiee, Haydeh ^{[1
]}

Tehranian, Afsaneh ^{[1
]}

Mozafar-Jalali, Sima ^{[1
]}

Sabet, Somayeh ^{[1
]}

机构：

[1] Univ Tehran Med Sci, Arash Hosp, Dept Gynecol, Tehran, Iran

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2011年 / 114卷 / 01期

关键词：

Endometrial ablation; Hysteroscopy; Menorrhagia; NovaSure; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; MENORRHAGIA; DEVICES; SAFETY;

D O I：

10.1016/j.ijgo.2010.12.023

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Objective: To evaluate the rate of response to treatment with the NovaSure endometrial ablation device among Iranian women with menorrhagia. Methods: Twenty 35-50-year-old women with menorrhagia who were referred to Arash Hospital, Tehran, Iran, in 2008 were enrolled. They underwent endometrial ablation via the NovaSure system and were followed-up for 2 years. Results: The incidence of amenorrhea was 30.0% at the end of the 2-year follow-up period. Hypomenorrhea was reported by 40.0% of women. The mean number of days of bleeding per month decreased significantly, from 30.0 +/- 6.4 days before treatment to 3.1 +/- 2.6 days after 2 years (P < 0.001). The severity of bleeding decreased significantly within 2 years after treatment (P < 0.001). In total, 85.0% of women were satisfied and 90.0% had responded to treatment-as defined by amenorrhea, hypomenorrhea, or return to normal menstruation. Conclusion: The NovaSure system is effective and should be considered by gynecologists for the treatment of menorrhagia. (C) 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

引用

页码：73 / 75

页数：3

共 19 条

[1]

A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding [J].